Sanofi India Limited Rs 48 Dividend 2026: Record Date, Ex-Date, Payment Date, Yield & Complete Details
Sanofi India has just announced a 48 rupees per share final dividend for FY-2025 - a move that's generating quite a buzz among dividend hunters and all the usual suspects in the stock market. As one of the top pharma multinationals in India and with a reputation for sending out dividend cheques like clockwork, this news is especially music to the ears of income-focused investors.
The article below has all the important details on this dividend payment, covering the lot from when the record date is, ex-date, payment dates, who's eligible and all that jazz
Sanofi India Rs 48 Dividend 2026 - Key Details
Sanofi India's board of directors in February 2026 gave the nod to a 48 rupee per share final dividend - but it's still waiting on shareholder approval.
- The dividend works out to 48 rupees per share.
- This is a final dividend payout (for FY-2025).
We can expect to hear more about this dividend in February 2026
Status: still waiting for shareholders to bless it
It's worth noting though that the total dividend payout for FY-2025 added up to around 123 rupees per share (with the interim dividend included) - a trend that's stable but hasn't been going up at all.
Why April 22 is THE Golden Date in the Stock Market
In the NSE/BSE, the Indian stock market, things have changed a bit with the T+1 and T+0 settlement cycles - the Ex-Dividend Date and the Record Date are now often the same date.
The Main Ex-Date (April 22nd, 2026):
To get the dividend, you'll need to buy those Sanofi India shares before this april 22 date. if you buy them on or after april 22nd, guess who gets the dividend? the previous owner.
The Record Date (April 22, 2026):
It's the day the company checks over its books to see who actually owns those shares.
What is the Sanofi India Dividend Payment Date for 2026?
As a general rule, Dividend is usually paid out within 25-45 days after the record date - and it pretty much follows what the regulatory norms say.
if you look at global Sanofi dividend payment schedules, payments are getting made within a day or two after the company confirms the record - which is pretty fast, I'd say.
Here's what we know about when to expect that ₹48 dividend payment:
AGM approval >Record Date >Payment in around 1 month, roughly.
How to Get Sanofi India Dividend? Check Eligibility
Receiving a dividend not exactly like collecting a rebate - it's basically a done deal if your financial affairs are in order. Here's what is required so you don't miss out:
Step 1: Timing Your Sanofi Shareholding
To get the dividend you need to have your Sanofi shares in your Demat account by the end of the Record Date - which brings us to the settlement times you need to buy those shares at latest 1-2 business days before the 22nd of April
Step 2: Make Sure Everything's In Place
- Dividends get paid straight into your bank via Electronic Clearing Service or NEFT.
- Just check your main bank account is linked to your Demat account (its likely you've done this via a broker like Zerodha, Upstox or ICICI Direct, but just to be certain).
- Double check your PAN card info is up to date - because if it's not you might end up with all 20% of your dividend cash clawed back in Tax Deducted at Source.
Step 3: Dividend Tax in India
Now it's worth remembering that dividends just don't get written off as tax free for Indian investors no more.
- If you get dividends totalling over ₹5,000 from Sanofi in a single year the company will knock off 10% TDS.
- The dividend income counts towards your income and you'll pay income tax on it according to your tax slab.
What is The Sanofi India dividend history and yield?
Sanofi India's got a pretty impressive history of doling out dividends - and that's one of the big reasons investors are interested in the company.
Recent Dividend History
- ₹117 per share - that was the final dividend for FY-2024.
- ₹75 per share - the interim dividend for FY-2025 was a bit lower.
- They are currently proposing another final dividend for FY 2025-26 - a sizeable ₹48 per share
- Long-Term Trend.
They have been handing out dividends for over 50 years now, since 2001.Even when the market's been going haywire they've managed to keep paying out and they're known for a high payout ratio - often even hitting over 100%.
Dividend Yield
The dividend yield is currently in the 3-5% ballpark, depending on the current stock price.
Key Insight
Now, that ₹48 dividend payout may look a bit lower than some of their previous payouts - but here's why:
- The company's profits have actually been going down lately.
- They're playing it a bit safer with their dividend payouts.
- They're prioritising long term sustainability over a single big payout.
What is about Sanofi India and Does?
To get a handle on the dividend, you need to be on top of what this business is all about. Sanofi India has gone through some significant changes over the past 24 months.
The Great Demerger (SIL vs. SCHIL)
In June 2024 , Sanofi India basically pulled apart and a major demerger occurred. This is no doubt the biggest point of confusion for investors right now. You now have two separate listed entities on the market:
Sanofi India Limited (SIL): This one is the company behind the ₹48 dividend. Its main focus areas are Specialty Care and Prescription Medicines. Think high-end insulin (like Lantus), cardiology (Cardace), and the stuff doctors prescribe for critical care.
Sanofi Consumer Healthcare India Limited (SCHIL): SCHIL handles all the consumer products - "Over-the-Counter" (OTC) brands such as Combiflam, Allegra, and Avil. SCHIL is paying its own dividend (it recently declared a ₹75 dividend), but it's a whole different stock
Key Business Segments of SIL
Sanofi India Limited is still a powerhouse in the chronic therapy space:
- Diabetes Care: They're basically the market leaders when it comes to insulin - their "Lantus" brand is well-known among diabetic patients.
- Cardiology & Thrombosis: They supply life-saving medications for heart health and blood pressure.
- Vaccines: They're one of the biggest players in private-market vaccines in India (think Hexaxim).
- CNS (Central Nervous System): Specialised treatments for epilepsy and other neurological conditions - the kind doctors prescribe.
Strategic Investments
It's not just churning out old pills - Sanofi is investing big at the moment. In mid-2024, they announced they were putting €400 million into a new Global Capacity Centre (GCC) in Hyderabad. By 2026, this hub has become vital to Sanofi's global AI & R&D operations - proving that the India unit is actually crucial to the parent company's long-term plans.
Is Sanofi India A Good Dividend Stock?
Sanofi India is seen by many as a top-notch dividend stock within the pharma sector.
The Good Stuff
- They've always paid a dividend, so that's a good thing.
- They hand out a big chunk of their profits back to shareholders.
- Its parent company is a well established and respected global player.
- Their business model is pretty steady.
And Some Worries
- They've been making less profit lately.
- Their dividend has actually been decreasing in recent years.
- They're not exactly the fastest growers in the pharma space.
The Bottom Line
If you're after steady income, then Sanofi India is a good bet, but if you're looking for something to really accelerate your wealth then this one might not be for you
Final Thoughts
It's an interesting move that the dividend has been brought down to 48 rupees - it suggests they're playing it a bit safer, focusing on protecting that dividend instead of trying to blow it all on growth. Sanofi India is still very much a reliable dividend payer in the pharma world, but keep an eye on that record date announcement, because when it comes to getting that dividend its all about timing.